A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2001
10/16/2001	US6303653 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
10/16/2001	US6303643 Therapy of migraine headache, hypertension, alcohol withdrawal, drug addiction, rheumatoid arthritis, presbyopia, ischemic pain, spasticity, diarrhea, nasal congestion, and urinary incontinence by administering benzothiazole derivative
10/16/2001	US6303639 Propanolamine derivatives substituted by heterocyclic radicals, processes for their preparation, pharmaceuticals comprising these compounds and their use
10/16/2001	US6303637 For therapy of autoimmune disease, prophylaxis of resistance to transplantation or transplantation rejection of organs or tissues; suppressing immune system
10/16/2001	US6303625 Triazolopyridines for the treatment of thrombosis disorders
10/16/2001	US6303615 2,3 disubstituded-4(3H)-quinazolinones
10/16/2001	US6303614 Tetrahydro gamma-carbolines
10/16/2001	US6303607 Administering sustained release pharmaceutical dosage form including ranolazine, ph-dependent and ph-independent binders to human suffering from variant or excercise-induced angina
10/16/2001	US6303603 3-oxo-2(H)-1,2,4-triazine derivatives as ligands of 5 HT1A receptors
10/16/2001	US6303600 Substituted azabicyclic compounds
10/16/2001	US6303573 Heart homing peptides and methods of using same
10/16/2001	US6303374 By hybridization with nucleic acid; controlling apoptosis and programmed cell death; alzheimers, parkinsons, autoimmune, and viral diseases; cancer; amyotrophic lateral sclerosis
10/16/2001	US6303333 Expression vector which codes polypeptides for the diagnosis and treatment of cancer, dietetics, inflammation, cardiovascular disorders, crohn's diseases, neuropathies and immune defects
10/16/2001	US6303314 T-cell receptor Vβ-Dβ-Jβ sequence and methods for its detection
10/16/2001	US6303141 Passive sustained release transdermal drug delivery system
10/16/2001	US6303127 Treatment of disease states
10/16/2001	US6303126 Treatment of fibrosis by HGF
10/16/2001	CA2144104C Peptide derivatives having binding activity to modified low density lipoprotein
10/16/2001	CA2089349C New pyrolidine derivatives, process for their preparation and pharmaceutical composition holding same
10/16/2001	CA2035967C Oxetanones
10/16/2001	CA2025301C New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase
10/13/2001	CA2344089A1 Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
10/11/2001	WO2001075170A1 A functional assay of high-density lipoprotein
10/11/2001	WO2001075168A1 Control of a gene induced by oxidized lipids in human artery wall cells
10/11/2001	WO2001075109A2 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability
10/11/2001	WO2001075108A1 Human ion channel protein and polynucleotides encoding the same
10/11/2001	WO2001075078A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
10/11/2001	WO2001074904A2 G-protein coupled receptors and nucleic acids encoding same
10/11/2001	WO2001074902A2 Adenine binding g protein coupled receptors
10/11/2001	WO2001074901A2 Polynucleotides and polypeptides, their use in diagnosis and treatment of cardiac, renal or inflammary disease
10/11/2001	WO2001074900A2 Nuclear factor kb inducing factor
10/11/2001	WO2001074896A1 Human polynucleotides, polypeptides, and antibodies
10/11/2001	WO2001074856A2 Wnt-7b-like polypeptides and nucleic acids encoding same
10/11/2001	WO2001074841A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
10/11/2001	WO2001074837A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
10/11/2001	WO2001074835A1 O-glucosylated benzamide sglt2 inhibitors and method
10/11/2001	WO2001074834A1 O-aryl glucoside sglt2 inhibitors and method
10/11/2001	WO2001074820A1 Novel derivatives and analogues of galanthamin
10/11/2001	WO2001074811A2 Substituted 1,3-thiazole compounds, their production and use
10/11/2001	WO2001074806A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001	WO2001074791A1 Diazepane derivatives or salts thereof
10/11/2001	WO2001074779A1 Aminopyridines and their use as anticonvulsants and sodium channel blockers
10/11/2001	WO2001074775A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
10/11/2001	WO2001074769A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/11/2001	WO2001074506A1 Extrusion die
10/11/2001	WO2001074413A1 Medical devices suitable for gene therapy regimens
10/11/2001	WO2001074400A1 Transporters and drug delivery system by using the same
10/11/2001	WO2001074395A2 Amiodarone-containing parenteral solution
10/11/2001	WO2001074394A1 New combination of a betablocker and a cholesterol-lowering agent
10/11/2001	WO2001074389A2 Improved treatment of neovascularization
10/11/2001	WO2001074385A1 Angiogenic onchocerca volvulus proteins and uses thereof
10/11/2001	WO2001074379A2 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
10/11/2001	WO2001074369A1 Divided dose therapies with vascular damaging activity
10/11/2001	WO2001074362A1 Inhibition of cyclooxygenase-2 activity
10/11/2001	WO2001074360A1 Therapeutic combinations of antihypertensive and antiangiogenic agents
10/11/2001	WO2001074359A1 Sigma receptor ligands and their medical uses
10/11/2001	WO2001074357A1 Hydrophilic molecular disperse solutions of carvedilol
10/11/2001	WO2001074356A1 Concentrated solutions of carvedilol
10/11/2001	WO2001074351A1 Composition for the prevention and/or treatment, in newborn babies, of the effects of complications during childbirth
10/11/2001	WO2001074348A2 Vasopeptidase inhibitors to treat isolated systolic hypertension
10/11/2001	WO2001074334A1 Controlled release pharmaceutical composition containing midodrine and/or desglymidodrine
10/11/2001	WO2001074299A2 Compositions and methods for inhibition of cancer invasion and angiogenesis
10/11/2001	WO2001034572A3 Carboxamide-substituted benzimidazol derivatives, method for the production thereof and their use as tryptase inhibitors
10/11/2001	WO2001027119A3 Substance library containing bicyclic imidazo-5-yl-amines and/or bicyclic imidazo-3-yl-amines
10/11/2001	WO2001025269A3 Human g-protein coupled receptor
10/11/2001	WO2001025210A3 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands
10/11/2001	WO2001021202A3 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells
10/11/2001	WO2001019826A3 Triazolopyrimidine derivatives
10/11/2001	WO2001007470A3 Human nervous system-associated proteins
10/11/2001	WO2000062736A3 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/11/2001	WO2000048606A9 Compositions and methods for use in targeting vascular destruction
10/11/2001	WO2000041472A3 Binding partners for 5-ht5-receptors for the treatment of migraine
10/11/2001	WO2000017176A3 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments
10/11/2001	US20010029314 Cardiac disease treatment and device
10/11/2001	US20010029304 Cyclopentane heptan (ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
10/11/2001	US20010029270 Aqueous solution
10/11/2001	US20010029260 Methods for treating hypertension and angina using salts of optically pure (-) amplodipine
10/11/2001	US20010029251 Administering cytomegalo virus protein
10/11/2001	US20010029249 Adenovirus comprising a gene coding for glutathione peroxidase
10/11/2001	US20010029248 Composition for and method of reducing low density lipoprotein cholesterol concentration
10/11/2001	US20010029040 Agent for gene therapy of dilated cardomyopathy
10/11/2001	US20010029034 Hemostasis system-related disorders treatment
10/11/2001	US20010029031 Polynucleotides encoding human sodium bicarbonate cotransporters
10/11/2001	CA2405496A1 Vasopeptidase inhibitors to treat isolated systolic hypertension
10/11/2001	CA2404965A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
10/11/2001	CA2404896A1 Human ion channel protein and polynucleotides encoding the same
10/11/2001	CA2404592A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
10/11/2001	CA2404576A1 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability
10/11/2001	CA2404541A1 G-protein coupled receptors and nucleic acids encoding same
10/11/2001	CA2404519A1 Wnt-7b-like polypeptides and nucleic acids encoding same
10/11/2001	CA2404484A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
10/11/2001	CA2404384A1 Substituted 1,3-thiazole compounds, their production and use
10/11/2001	CA2404376A1 O-glucosylated benzamide sglt2 inhibitors and method
10/11/2001	CA2404373A1 O-aryl glucoside sglt2 inhibitors and method
10/11/2001	CA2404350A1 Control of a gene induced by oxidized lipids in human artery wall cells
10/11/2001	CA2404300A1 Medical devices suitable for gene therapy regimens
10/11/2001	CA2404298A1 Amiodarone-containing parenteral solution
10/11/2001	CA2404074A1 Human polynucleotides, polypeptides, and antibodies
10/11/2001	CA2403991A1 Aminopyridines and their use as anticonvulsants and sodium channel blockers
10/11/2001	CA2403886A1 Controlled release pharmaceutical composition containing midodrine and/or desglymidodrine

1 ... 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 ... 1595